Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S. Katibian DJ, et al. Among authors: hibi t. Clin Gastroenterol Hepatol. 2024 Jan;22(1):22-33.e6. doi: 10.1016/j.cgh.2023.08.039. Epub 2023 Sep 15. Clin Gastroenterol Hepatol. 2024. PMID: 37716619 Review.
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.
Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Ueno F, et al. Among authors: hibi t. J Gastroenterol. 2013 Jan;48(1):31-72. doi: 10.1007/s00535-012-0673-1. Epub 2012 Oct 23. J Gastroenterol. 2013. PMID: 23090001 Free PMC article.
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
Dubinsky M, Bleakman AP, Panaccione R, Hibi T, Schreiber S, Rubin D, Dignass A, Redondo I, Gibble TH, Kayhan C, Travis S. Dubinsky M, et al. Among authors: hibi t. Am J Gastroenterol. 2023 Nov 1;118(11):1940-1953. doi: 10.14309/ajg.0000000000002404. Epub 2023 Jun 12. Am J Gastroenterol. 2023. PMID: 37436151 Free PMC article. Review.
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.
Dubinsky MC, Jairath V, Feagan BG, Naegeli AN, Tuttle J, Morris N, Shan M, Arora V, Lissoos T, Agada N, Hibi T, Sands BE. Dubinsky MC, et al. Among authors: hibi t. BMJ Open Gastroenterol. 2023 Mar;10(1):e001115. doi: 10.1136/bmjgast-2023-001115. BMJ Open Gastroenterol. 2023. PMID: 37001911 Free PMC article. Clinical Trial.
Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis.
Kawa S, Okazaki K, Notohara K, Watanabe M, Shimosegawa T; Study Group for Pancreatitis Complicated with Inflammatory Bowel Disease organized by The Research Committee for Intractable Pancreatic Disease (Chairman: Tooru Shimosegawa) and The Research Committee for Intractable Inflammatory Bowel Disease (Chairman: Mamoru Watanabe), both of which are supported by the Ministry of Health, Labour, and Welfare of Japan. Kawa S, et al. J Gastroenterol. 2015 Jul;50(7):805-15. doi: 10.1007/s00535-014-1012-5. Epub 2014 Nov 16. J Gastroenterol. 2015. PMID: 25399203
Genetics of inflammatory bowel disease in Japan.
Hibi T. Hibi T. J Gastroenterol. 2010 May;45(5):567. doi: 10.1007/s00535-010-0215-7. Epub 2010 Mar 2. J Gastroenterol. 2010. PMID: 20195648 No abstract available.
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.
Kobayashi T, Hisamatsu T, Motoya S, Fujii T, Kunisaki R, Shibuya T, Matsuura M, Takeuchi K, Hiraoka S, Yasuda H, Yokoyama K, Takatsu N, Maemoto A, Tahara T, Tominaga K, Shimada M, Kuno N, Fernandez JL, Ishiguro K, Cavaliere M, Deguchi H, Hibi T. Kobayashi T, et al. Among authors: hibi t. Intest Res. 2025 Jan 16. doi: 10.5217/ir.2024.00063. Online ahead of print. Intest Res. 2025. PMID: 39818201 Free article.
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.
Nakase H, Danese S, Reinisch W, Ritter T, Liang Y, Wendt E, Levesque BG, Yoon OK, Tian Y, Zhuo L, Karouzakis E, Bauer Y, Oortwijn A, Kaise T, Malkov VA, Hibi T. Nakase H, et al. Among authors: hibi t. Inflamm Bowel Dis. 2024 Dec 4:izae278. doi: 10.1093/ibd/izae278. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39656830
1,268 results